Last reviewed · How we verify
placebo (for midazolam)
A placebo has no active pharmacological mechanism; it produces therapeutic effects through psychological and psychophysiological processes.
A placebo has no active pharmacological mechanism; it produces therapeutic effects through psychological and psychophysiological processes. Used for Control arm in midazolam clinical trials.
At a glance
| Generic name | placebo (for midazolam) |
|---|---|
| Also known as | normal saline |
| Sponsor | Konkuk University Medical Center |
| Modality | Small molecule |
| Therapeutic area | Clinical Research / Control |
| Phase | FDA-approved |
Mechanism of action
Placebos are inert substances used as controls in clinical trials. Any observed effects result from patient expectation, the therapeutic context, and natural disease progression rather than direct drug action. In this case, it serves as a control comparator for midazolam, a benzodiazepine anxiolytic and sedative.
Approved indications
- Control arm in midazolam clinical trials
Common side effects
Key clinical trials
- SMILE Trial - Imaging Sub-Study
- Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis (PHASE1)
- Safety and Efficacy of Dexmedetomidate vs. Midazolam for Procedural Sedation During Medical Thoracoscopy (PHASE3)
- A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder (PHASE3)
- Ketamine, SGB and Combination Treatment for TBI (PHASE2)
- KF2022#4-trial: Effects of a Beta Blocker and NSAID on CYP Mediated Drug Metabolism (NA)
- Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS) (PHASE3)
- A First-in-human Trial of GRT7041 in Healthy Participants (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- placebo (for midazolam) CI brief — competitive landscape report
- placebo (for midazolam) updates RSS · CI watch RSS
- Konkuk University Medical Center portfolio CI